Document Detail


In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent.
MedLine Citation:
PMID:  22082579     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Aims: The objective of this study was to investigate the structural integrity and early vascular response of a polylactic acid-coated (i.e., biodegradable polymer) coronary drug-eluting stent (DES) (BioMatrix™; Biosensors International, Singapore) to three currently marketed FDA/CE- mark approved non-erodible polymer-coated DES in a porcine model. Methods and results: BioMatrix™, XIENCE V™ (Abbott Vascular, Santa Clara, CA, USA), TAXUS® Liberté™ (Boston Scientific, Natick, MA, USA), and Cypher SELECT™ (Cordis, Johnson & Johnson, Miami, FL, USA) stents were implanted in pig coronaries for seven days. Polymer integrity was assessed by scanning electron microscopy (SEM) following tissue digestion. In vitro expansion of the BioMatrix™ was also performed. SEM analysis of in vivo stents demonstrated polymer defects on the abluminal surface of all DES including polymer cracking (BioMatrix™), bridging (TAXUS Liberté™), round-small defects (Cypher SELECT™), and flaking (XIENCE V™). Histologically, the myocardium revealed no evidence of acute myocardial infarction or microscopic scarring, moreover all intramyocardial vessels were found to be patent with no evidence of emboli. In vitro results demonstrated greater BioMatrix™ polymer cracking and lifting. Conclusions: These results illustrate the presence of polymer defects in all DES (TAXUS Liberté™, Cypher SELECT™, XIENCE V™, BioMatrix™) implanted seven-days in pigs, with absence of myocardial damage in this small number of samples. Polymer coating irregularity was greater in BioMatrix™ stent expanded in vitro as compared to in vivo, suggesting simulated benchtop deployment induces greater damage to the biodegradable polymer coating than in vivo deployment in healthy porcine coronary arteries.
Authors:
Saami K Yazdani; Marc Vorpahl; Masataka Nakano; Shih-Horng Su; Frank D Kolodgie; Renu Virmani
Related Documents :
9384389 - Temporary occlusion of the middle cerebral artery in intracranial aneurysm surgery: tim...
10756249 - Are changes in myocardial integrated backscatter restricted to the ischemic zone in acu...
21964159 - Postconditioning modulates ischemia-damaged mitochondria during reperfusion.
3711509 - In vivo prediction of the transmural extent of experimental acute myocardial infarction...
6475709 - Mechanisms of ventricular arrhythmias in multivessel coronary disease: the effects of c...
912839 - The wavefront phenomenon of ischemic cell death. 1. myocardial infarct size vs duration...
11090799 - Factors associated with preventable out-of-hospital nontraumatic cardiac arrest.
8870569 - Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infa...
21067399 - Myocardial fibrosis in hypertrophic cardiomyopathy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  7     ISSN:  1969-6213     ISO Abbreviation:  EuroIntervention     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  France    
Other Details:
Languages:  eng     Pagination:  835-43     Citation Subset:  IM    
Affiliation:
CVPath Institute, Inc., Gaithersburg, MD, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons.
Next Document:  Percutaneous renal artery intervention versus medical therapy in patients with renal artery stenosis...